Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications - Top-Institutions - MDSpire

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications

  • By

  • Berlinde von Kemp

  • Xavier Galloo

  • Bram Roosens

  • Bart Neyns

  • Rik Schots

  • Mark De Ridder

  • Bernard Cosyns

  • June 9, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Universitair Ziekenhuis Brussel
    Universitair Ziekenhuis Brussel

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Cardio-Oncology

  • #2

    Amsterdam UMC
    Amsterdam UMC

    Amsterdam, North Holland

    Key Differentiators

    • Cardio-Oncology

  • #3

    Emma Children’s Hospital
    Emma Children’s Hospital

    Amsterdam, North Holland

    Key Differentiators

    • Pediatric Cardiology

  • #4

    Radboud University Medical Center
    Radboud University Medical Center

    Nijmegen, Gelderland

    Key Differentiators

    • Cardio-Oncology

Original Source(s)

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications

  • by Berlinde von Kemp, Xavier Galloo, Bram Roosens, Bart Neyns, Rik Schots, Mark De Ridder, Bernard Cosyns

  • June 9, 2026

Related Content

Exercise in regional breast cancer with neoadjuvant anthracycline-based chemotherapy with immune checkpoint-inhibition: study protocol for a prospective randomised controlled trial

A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

Value of point-of-care ultrasound in the early identification of left ventricular dysfunction and prognostic assessment in cancer patients complicated by sepsis